Skip to main content
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Our Founders
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > Prizes > Prize Recipients > Mohamed Abou Donia

Mohamed Abou Donia

2021 Vilcek Prize for Creative Promise in Biomedical Science

Location

Princeton, NJ

Title

Associate Professor, Department of Molecular Biology, Princeton University

Area(s) of Research

Microbial communities, drug-microbiome interactions, symbiosis, biochemistry

Education

Suez Canal University (BS, Pharmacy);
University of Utah (PhD, Medicinal Chemistry)

Country of Birth

Egypt

Follow Mohamed Abou Donia
Twitter
Links to learn more about Mohamed Abou Donia's work
  • princeton.edu

Tags
biochemistry biomedical science egypt metabolism microbes microbiome Princeton University symbiosis university of utah
Share this page
Twitter Facebook LinkedIn

Mohamed, arms crossed and wearing a lab coat, stands in his Princeton University lab.

Mohamed Abou Donia is fascinated by the relationships between organisms and their communities. “We all live together in diverse communities and we interact with other humans, animals, plants, as well as microbes everywhere,” he says. “The focus of my work is basically to understand the interactions between higher organisms and their microbial partners.”

Abou Donia first came to his career through the study of pharmacy. Born in Ismailia, Egypt, Abou Donia grew up about 100 miles outside of Cairo. Loving mathematics and sciences in high school, he initially enrolled in medical school before deciding to transfer to study pharmacy at Suez Canal University in Egypt. “I’ve always been fascinated by how small-molecule drugs or chemicals affect humans: how we develop chemicals, how they affect our body, and how they treat diseases.” He cites the holistic view that studying pharmacy gave to understanding human diseases—the causes and pathologies of diseases, the biochemical processes underlying them at a molecular and cellular level, and the entire pipeline of pharmaceutical drug development to treat them.

Mohamed Abou Donia at age 3, wearing a blue and white sweater.
Abou Donia at approximately 3 years old in Ismailia, Egypt.

Though Abou Donia loved the science of pharmacy, he found an internship working at a pharmacy unfulfilling. His older sister—who pursued a PhD in pharmacognosy—inspired him to consider a path in academic research. The following summer, Abou Donia had the opportunity to work in a research laboratory in the United States. The experience was enlightening, and cemented his desire to pursue a PhD and a career in research.

Mohamed pointing to a computer monitor while a student observes.

Abou Donia is an associate professor at Princeton University, where he has run a laboratory since 2014. His research focuses on the chemical interactions that occur within complex microbiomes and between microbiomes and their host organisms, such as humans, marine invertebrates, and marine algae, and the impacts of these interactions on host health and metabolism. Abou Donia has identified drug-like molecules, including antibiotics, produced by the human microbiome. His research work has led to the development of screening methods to reveal with individual-level precision how drugs are metabolized by the human gut microbiome, and mapped microbiome-encoded genes involved in drug metabolism.

Mohamed, wearing a lab coat and mask, adjusts lab equipment.

Additionally, Abou Donia’s work has led to a molecular understanding of the role of microbiome-derived chemical defense in the evolution of intricate symbioses between marine organisms. His laboratory’s broad approach to the research questions of microbiome-host chemical interactions—in humans, marine algae, and marine invertebrates—enables Abou Donia and his colleagues to develop a comprehensive understanding of the diverse types of relationships between organisms and their microbiomes, as well as identify common themes and principles that support life on Earth.

“While we are just getting started, my long-term goal is to take these discoveries to the field and clinic, with direct implications for environmental conservation and medical applications.”

 

Awards and Accomplishments

  • The Pershing Square Sohn Prize for Young Investigators in Cancer Research (2020)
  • Theobald Smith Society Young Investigator Award (2020)
  • Symbiosis in Aquatic Systems Investigator Award, Gordon and Betty Moore Foundation (2020)
  • ASPIRE Award, Pfizer (2018)
  • Dean for Research Innovation Award for New Ideas in the Natural Sciences, Princeton University (2018)
  • Pew Biomedical Scholar, The Pew Charitable Trusts (2017)
  • NIH Director’s New Innovator Award, National Institutes of Health (2015)
  • Kenneth Rainin Foundation Innovator and Breakthrough Awards (2015–17)

Follow Mohamed Abou Donia

Twitter
Tags
biochemistry biomedical science egypt metabolism microbes microbiome Princeton University symbiosis university of utah

Jury Members

2021 Vilcek Prize for Creative Promise in Biomedical Science

Heran Darwin

Professor, Department of Microbiology, New York University

Laurie Dempsey

Senior Editor, Nature Immunology, Nature Publishing Group

Yibin Kang

Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University

Harmit S. Malik

Principal Investigator, Fred Hutchinson Cancer Research Center

Luciano A. Marraffini

Kayden Family Professor, The Rockefeller University

Leslie B. Vosshall

Robin Chemers Neustein Professor of Neurogenetics and Behavior, The Rockefeller University

Jedd D. Wolchok

Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation, Memorial Sloan Kettering Cancer Center
Share this page
Twitter Facebook LinkedIn

Related Prize Recipients

Martin Jonikas

Martin Jonikas receives the Vilcek Prize for Creative Promise in Biomedical Science for molecular studies on Chlamydomonas, a model photosynthetic organism, with long-term implications for improving food-crop yield and combating climate change.
Portrait of Martin Jonikas

Edward Chouchani

Edward Chouchani receives the Vilcek Prize for Creative Promise in Biomedical Science for his work to decipher the molecular mechanisms that drive metabolic disease, with the aim of developing therapeutic interventions targeted at the molecular drivers of metabolism within cells.
Portrait of Edward Chouchani.

Harris Wang

Harris Wang receives the Vilcek Prize for Creative Promise in Biomedical Science for the development and application of Mutiplex Automated Genome Engineering (MAGE), a platform to track, program, and engineer entire microbial communities and ecosystems for a range of diagnostic and therapeutic applications.
Portrait of Harris Wang

You may also be interested in

November 3, 2021

Worlds Inside: Manga Explores the Work of Biochemist Mohamed Abou Donia

The second in our manga series honoring Vilcek Foundation Prizewinners, developed in partnership with Hiroki Otsuka.
March 8, 2021

Mohamed Abou Donia: “How our microbial partners affect our health.”

Mohamed Abou Donia studies small-molecule-mediated interactions in complex microbial communities, and their impact on host health, including humans and other organisms.
Mohamed Abou Donia framed by an archway of one of the Princeton University buildings.
April 13, 2023

Edward Chouchani seeks to understand the role of metabolism in disease

Born in Canada, biochemist and cell biologist Edward Chouchani uses mass spectrometry to illuminate the metabolic pathways that drive cellular function and disease.
A portrait of Edward Chouchani smiling.

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Our Founders
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2023   Vilcek Foundation